Fewer, larger, more selective: what the first half of 2026 tells us about where private capital is going in MedTech, and how investors should think about carve-outs, take-privates and the categories that are attracting the biggest cheques. The headline number for MedTech M&A in 2026 is striking. In the first half of the year, deal value was roughly 160% higher than the same period in 2025. The more interesting number sits beside it: deal count rose by just 5%. Average deal v

European HealthTech continues to see heavy capital flow toward clinical workflow automation, platform consolidation and regulatory alignment under evolving EU frameworks. Tandem Health (Sweden) raised $100M in Series B funding, backed by the EU's €5B tech startup initiative, to scale its clinical workflow and administrative AI platform across European healthcare networks. Venture capital continues shifting decisively away from standalone consumer wellness apps, heavily pr

Nine months ago, Angle Health closed what looked like a strong Series B. The San Francisco health benefits company raised $134 million in a mix of debt and equity led by Portage, bringing its total funding to just under $200 million. It was a respectable round for a company that most people outside the US employer benefits market had never heard of. Now, according to the Wall Street Journal, European mid market private equity firm Vitruvian Partners is leading a $600 Million

Every year, the NHS in England delivers roughly 120 million outpatient appointments. Two thirds of them are follow-ups. And, according to the chair of NHS England, almost nobody in the system believes this is a sensible way to spend clinical time, patient time or public money. Speaking at the King's Fund last week, one year on from the publication of the 10 Year Health Plan, Penny Dash made a remark that will resonate with anyone who has spent time in health policy circles. A

The convergence of high profile investment and digital health reflects a fundamental shift in medical care: transitioning from reactive, episodic treatment to continuous, predictive and consumer centric health management. High net worth cultural figures, particularly elite athletes such as Cristiano Ronaldo and LeBron James, alongside cultural entrepreneurs like Gwyneth Paltrow, are shifting their capital from traditional lifestyle endorsements to equity stakes in deep di

It is called Te Papa Hauora, the Christchurch Health Precinct and what began as a rebuilding project after the 2010–2011 Canterbury earthquakes has evolved into something closer to a deliberate industrial strategy. Cumulative investment across its public hospital rebuilds, university and polytechnic campuses, and commercial healthtech space now runs well past the billion dollar mark and the momentum is starting to attract attention well beyond New Zealand's shores.

Switzerland's medical technology industry is having a strange kind of year. By almost every headline measure, it is thriving: output is expanding at twice the rate of the broader Swiss economy, exports are climbing, and research spending remains among the highest of any industrial sector in the country. Yet beneath those numbers, the people who run the country's medtech companies are sounding an alarm that has been building for several years and has now become impossible to i

The NHS IT market is entering one of its most consequential growth phases in years. New analysis from Future Health Intelligence (FHI) forecasts that spending on NHS technology will climb from £6.1bn today to £8.3bn by 2030, adding more than £2bn in new market value over the next four years and cementing digital health as one of the fastest-growing corners of the UK public sector IT landscape. For an industry that has weathered its share of false starts and stop-go funding cy

Transformation Capital, the largest dedicated digital health venture and growth equity firm, has announced the final close of its fourth fund, Transformation Capital Fund IV, at an $850 million hard cap. The raise came in oversubscribed, with the firm completing the close this summer after exceeding its original target. It's a milestone that says as much about the state of digital health investing in 2026 as it does about Transformation Capital itself, and it's worth unpackin

There was no keynote, no press release, no carefully art-directed product shot. Apple's latest acquisition surfaced the way most of its acquisitions do: through a regulatory filing nobody was supposed to notice. Buried in the European Union's database of mergers likely to be significant in the region, a single entry revealed that Apple had acquired Sonera, a Berkeley born startup that builds non-invasive sensors capable of reading neural signals straight from the brain and bo

On 14th September 2026, Stockholm-based Tandem Health announced a $100 million (€86.5 million) Series B led by the Scaleup Europe Fund, the €5 billion vehicle managed by EQT and seeded by the European Commission, Novo Holdings, CriteriaCaixa and Santander. Existing backers Kinnevik, Northzone, Amino Collective and Visionaries all followed on. The round takes Tandem's total funding to roughly $160 million, barely fifteen months after its $50 million Series A and makes it the b

We tend to think of health security in terms of things we can see under a microscope or feel in a fever. Pandemics, antimicrobial resistance, contaminated water, the next novel virus. These are the threats that governments plan for, that the World Health Organization tracks and that most of us instinctively recognise as matters of life and death. There is a newer threat on that list, and it does not come from a pathogen. It comes from a laptop, often thousands of miles away,

OpenEvidence has established itself as the preeminent artificial intelligence platform in United States clinical practice, commonly referred to across the digital health ecosystem as the "ChatGPT for Doctors". Conceived by serial technologist Daniel Nadler and machine learning researcher Zachary Ziegler, the platform was developed to address an acute structural crisis in modern medicine: the velocity of peer-reviewed biomedical literature, which currently doubles every 73 day

The European digital health and healthcare technology sector is undergoing an institutional realignment. Valued at approximately $96.68 billion in 2025 and projected to expand to $222.22 billion by 2030 at a compound annual growth rate (CAGR) of 18.11%, the market has moved beyond the speculative retail funding cycles that characterised the zero interest rate policy (ZIRP) era. Alongside this software-driven expansion, the broader European medical technology industry maintai

Activity across European HealthTech this week centred on remote patient monitoring, clinical AI infrastructure, and EU-backed commercial rollouts. Activity across European Health AI this week centred around digital twins, Neuro AI and guidelines for the use of AI across the NHS. Activity across European MedTech this week centred on implants, preventative imaging, regulation and rehabilitation.